|
ATXS Astria Therapeutics Inc 1454789 |
| Balance Sheet |
|
Current Assets
|
351,863,000 |
|
Assets
|
361,639,000 |
|
Current Liabilities
|
15,724,000 |
|
Liabilities
|
19,985,000 |
|
Equity
|
341,654,000 |
|
Shares Out
|
56,425,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-63,850,000 |
|
Investing Cash Flow
|
-188,146,000 |
| Market Analysis |
Market Cap
|
641,555,313 |
|
Price
|
6.38 |
|
BVPS
|
6.06 |
|
PB
|
0.50 |
|
EPS
|
-2.30 |
|
PS
|
1.28 |
|
FCF
|
-251,996,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ATXS documents filed with the SEC.
ATXS Filings
Clear
